Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Free Cash Flow (2018 - 2026)

Dyadic International (DYAI) posted Free Cash Flow of -$2.0 million for Q1 2026, down 10.92% sequentially from -$1.8 million in Q4 2025, and down 0.7% YoY from -$2.0 million in Q1 2025.

Dyadic International (DYAI) Free Cash Flow (2018 - 2026) Analysis & Trends

Dyadic International has reported Free Cash Flow for 9 years, with the latest figure at -$2.0 million in Q1 2026.

  • Quarterly Free Cash Flow fell 0.7% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.7 million (down 18.79% YoY) and the FY2025 annual result came in at -$5.7 million, down 43.46% from the prior year.
  • Free Cash Flow declined to -$2.0 million in Q1 2026 per DYAI's latest filing, from -$1.8 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$130015.0 in Q2 2025 and troughed at -$2.9 million in Q1 2022.
  • A 5-year average of -$1.6 million and a median of -$1.8 million in 2022 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2022 and 2025: Free Cash Flow surged 99.85% in 2022, then slumped 821.31% in 2025.
  • Over 5 years, Free Cash Flow stood at -$1.7 million in 2022, then soared by 45.09% to -$923380.0 in 2023, then gained by 24.58% to -$696395.0 in 2024, then tumbled by 154.18% to -$1.8 million in 2025, then declined by 10.92% to -$2.0 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$2.0 million, -$1.8 million, and -$1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Dyadic International 19.98 Mn 19.98 Mn - -1.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.96 Mn
Mar 31, 2026 -1.96 Mn
Dec 31, 2025 -1.77 Mn
Dec 31, 2025 -1.77 Mn
Sep 30, 2025 -1.85 Mn
Sep 30, 2025 -1.85 Mn
Jun 30, 2025 -130,015.00
Jun 30, 2025 -130,015.00
Mar 31, 2025 -1.95 Mn
Mar 31, 2025 -1.95 Mn
Dec 31, 2024 -696,395.00
Dec 31, 2024 -696,395.00
Sep 30, 2024 -201,057.00
Sep 30, 2024 -201,057.00
Jun 30, 2024 -1.96 Mn
Jun 30, 2024 -1.96 Mn
Mar 31, 2024 -1.11 Mn
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 -923,380.00
Dec 31, 2023 -923,380.00